Drug Type Fc fusion protein |
Synonyms Long acting glucagon like peptide 2 Genexine, GX G8, GXG8 |
Target |
Action agonists |
Mechanism GLP-2R agonists(Glucagon-like peptide 2 receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Short Bowel Syndrome | Phase 1 | Europe | 13 May 2020 | |
Diarrhea | Preclinical | South Korea | - |